PATENT CLAIM ANALYSIS

Application Number: 16042917
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["435", "366000"]

Abstract:
Disclosed herein are methods, compositions, kits, and agents useful for inducing β cell maturation, and isolated populations of SC-β cells for use in various applications, such as cell therapy.

Claim (Index 10):
The device of  claim 2 , wherein the population of non-native pancreatic \u03b2 cells comprises between 340-748 million non-native pancreatic \u03b2 cells.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.25
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14684101', '14975158', '15478094', '14670249', '12167227']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6404132505340152
- 35 USC 102 Novelty (BERT): 0.5961879331865715
- Combined Prediction Score: 0.6359907187992708
- Mean Citation Score: 422.614236
- Max Citation Score: 630.4137599999998
- Similarity Product: 425.44358559837326

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test